cambridge-epigenetix
Cambridge Epigenetix (now rebranded as biomodal) is a life sciences tools company revolutionizing genome sequencing by enabling simultaneous genetic and epigenetic analysis from a single DNA sample. Its duet multiomics platform distinguishes multiple cytosine modifications to provide a 6-base genome view, enabling earlier and more accurate detection of cancer and other diseases through liquid biopsy and research applications.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountUnknown
Nov 2021
Jan 2018
Mar 2016
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
